<DOC>
	<DOC>NCT00515424</DOC>
	<brief_summary>This study will evaluate the tolerability and safety of RKI983 ophthalmic solution and explore the effect of the compound on intraocular pressure in subjects with ocular hypertension.</brief_summary>
	<brief_title>Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<criteria>Males and females, â‰¥18 years of age, with primary open angle glaucoma and ocular hypertension Females must be postmenopausal or surgically sterile Other types of glaucoma Eye pressure lowering surgeries A history of or current eye conditions or medical problems that would prohibit the use of an investigational drug Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Ocular Hypertension</keyword>
	<keyword>RKI983</keyword>
	<keyword>Primary Open Angle Glaucoma and Ocular Hypertension</keyword>
</DOC>